Troluce Capital Advisors LLC Gh Research PLC Put Options Transaction History
Troluce Capital Advisors LLC
- $209 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GHRS
# of Institutions
42Shares Held
38.5MCall Options Held
5KPut Options Held
5.5K-
Bvf Inc San Francisco, CA8.83MShares$94.5 Million4.28% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.94MShares$74.3 Million1.59% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.44MShares$69 Million26.28% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$58.8 Million0.99% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$21.5 Million2.35% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $557M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...